Assessing the Skin and UV Neoplasia Transplant Risk Assessment Calculator in an Irish cohort of thoracic organ transplant recipients.

Autor:	Yoo LJH; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland., Bowe S; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland., Quigley C; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland., Victory L; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland., Devenney C; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland., Lenane P; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
Jazyk:	angličtina
Zdroj:	Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Dec 19; Vol. 49 (1), pp. 68-70.
DOI:	10.1093/ced/llad298
Abstrakt:	The Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) is a tool that can be used to decide when to first screen for skin cancer in organ transplant recipients (OTRs). The objective of this study was to assess the applicability of this tool in thoracic OTRs. Based on data from patient files, the OTRs were categorized into four risk groups according to the SUNTRAC tool. The time of the first post-transplant skin cancer in each OTR was recorded. The proportion of OTRs with post-transplant skin cancer in the low-, medium-, high- and very high-risk groups was 0%, 28.3%, 58.3% and 100%, respectively. This positive correlation suggests that SUNTRAC can be used to determine when to first screen for skin cancer in heart and lung OTRs. Competing Interests: Conflicts of interest The authors declare no conflicts of interest. (© The Author(s) 2023. Published by Oxford University Press on behalf of British Association of Dermatologists. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu